Your browser doesn't support javascript.
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.
Fragoulis, George E; Karamanakos, Anastasios; Arida, Aikaterini; Bournia, Vasiliki-Kalliopi; Evangelatos, Gerasimos; Fanouriakis, Antonis; Fragiadaki, Kalliopi; Kravvariti, Evrydiki; Laskari, Katerina; Panopoulos, Stylianos; Papazoglou, Nikolaos; Pappa, Maria; Tektonidou, Maria G; Sfikakis, Petros P.
  • Fragoulis GE; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece geofragoul@yahoo.gr.
  • Karamanakos A; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Arida A; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Bournia VK; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Evangelatos G; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Fanouriakis A; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Fragiadaki K; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Kravvariti E; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Laskari K; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Panopoulos S; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Papazoglou N; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Pappa M; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Tektonidou MG; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Sfikakis PP; Joint Academic Rheumatology Program, First Department of Propedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
RMD Open ; 8(1)2022 03.
Article in English | MEDLINE | ID: covidwho-1731300
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Rmdopen-2022-002279

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / Rheumatic Diseases / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Year: 2022 Document Type: Article Affiliation country: Rmdopen-2022-002279